Grifols S.A. (GRFS)
NASDAQ: GRFS
· Real-Time Price · USD
7.14
-0.16 (-2.19%)
At close: May 09, 2025, 3:59 PM
7.10
-0.56%
After-hours: May 09, 2025, 04:01 PM EDT
-2.19% (1D)
Bid | 6.5 |
Market Cap | 5.65B |
Revenue (ttm) | 7.36B |
Net Income (ttm) | 191.49M |
EPS (ttm) | 0.26 |
PE Ratio (ttm) | 27.46 |
Forward PE | 6.63 |
Analyst | n/a |
Ask | 8 |
Volume | 1,031,770 |
Avg. Volume (20D) | 1,068,006 |
Open | 7.22 |
Previous Close | 7.30 |
Day's Range | 7.12 - 7.28 |
52-Week Range | 5.79 - 9.96 |
Beta | 0.93 |
About GRFS
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol GRFS
Website n/a
5 months ago
Grifols shares are trading lower after the company...
Unlock content with
Pro Subscription
5 months ago
+5.06%
Grifols shares are trading higher following a report suggesting banks are preparing to submit final offers for a buyout debt deal.

1 month ago · businesswire.com
IBL International collaborates with Grifols on advanced biomarker panelsMÄNNEDORF, Switzerland--(BUSINESS WIRE)--IBL International GmbH, a Tecan company, which develops, manufactures and offers specialty diagnostics, today announced a strategic partnership with Grifols, a...

2 months ago · seekingalpha.com
Grifols: Looking At The Longer-Term 2025-2027 Upside After No SaleGrifols remains a strong long-term investment due to its leading position in the plasma industry and improving financial fundamentals, despite short-term volatility and lack of a dividend. The company...